Filing Details
- Accession Number:
- 0001209191-22-018864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-15 17:01:09
- Reporting Period:
- 2022-03-11
- Accepted Time:
- 2022-03-15 17:01:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1659323 | Iterum Therapeutics Plc | ITRM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1734033 | M. Judith Matthews | C/O Iterum Therapeutics Plc Fitzwilliam Court, Fl. 1, Leeson Close Dublin 2 L2 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2022-03-11 | 100,000 | $0.00 | 128,632 | No | 4 | A | Direct | |
Ordinary Shares | Disposition | 2022-03-14 | 47,132 | $0.38 | 81,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Restricted Share Units | Disposition | 2022-03-11 | 100,000 | $0.00 | 100,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,000 | No | 4 | M | Direct |
Footnotes
- Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
- On March 11, 2021, the reporting person was granted an award of 200,000 RSUs, 50% of which vested on March 11, 2022.